Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis
Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis
Overall Grade: F (Concerning)
View interactive company profile →
Guardian Pharmacy Services, Inc. faces challenges in financial performance that warrant careful analysis.
Key Metrics:
| Metric | Value | Context |
|---|---|---|
| ROIC | 20.8% | Above industry average |
| FCF Margin | 6.3% | Healthy cash flow |
Investment Thesis: Strong return on invested capital of 20.8% suggests durable competitive advantages and efficient capital allocation.
What is Guardian Pharmacy Services, Inc.'s Profitability and ROIC?
Guardian Pharmacy Services, Inc. generates strong returns on invested capital at 20.8%, indicating efficient capital allocation and competitive advantages. Gross margin of 19.7% with operating margin at 4.2% reflects the company's moderate market position.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 20.8% | Excellent | Strong capital efficiency |
| Gross Margin | 19.7% | Warning | Competitive pricing environment |
| Operating Margin | 4.2% | Warning | Moderate operational efficiency |
How Strong is Guardian Pharmacy Services, Inc.'s Cash Flow Quality?
Guardian Pharmacy Services, Inc. generated $88.0M in free cash flow over the trailing twelve months, representing a 6.3% margin. Cash earnings quality is strong, with operating cash flow exceeding net income by 2.2x.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| Free Cash Flow Margin | 6.3% | Adequate | Healthy cash generation |
| Free Cash Flow (TTM) | $88.0M | Good | Positive cash generation |
| OCF/Net Income | 2.2x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
What is Guardian Pharmacy Services, Inc.'s Financial Health?
Is Guardian Pharmacy Services, Inc. Stock Overvalued or Undervalued?
Guardian Pharmacy Services, Inc. trades at a P/E of 38.0x, representing a premium to the sector median of N/A. Free cash flow yield of 6.5% offers attractive cash returns.
Key Metrics
| Metric | Value | Rating | Interpretation |
|---|---|---|---|
| P/E Ratio | 38.0x | Adequate | Premium valuation |
| EV/Sales | -0.0x | Excellent | Attractive revenue multiple |
| FCF Yield | 6.5% | Good | Attractive cash return |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Return on Invested Capital (ROIC) | 20.8% | Top 50% | 2.1x above |
| Free Cash Flow Margin | 6.3% | Top 50% | 2.0x above |
| Gross Margin | 19.7% | Bottom 25% | 0.5x below |
| Operating Margin | 4.2% | Bottom 50% | 0.9x below |
| P/E Ratio | 38.0x | N/A | - |
Rating Thresholds
Return on Invested Capital (ROIC)
Measures how efficiently a company uses its debt and equity capital to generate profits. ROIC above 15% typically indicates a competitive moat.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 20% | Exceptional capital efficiency, strong competitive moat |
| Good | 12% - 20% | Above-average returns, sustainable competitive position |
| Adequate | 8% - 12% | Around cost of capital, moderate competitive position |
| Warning | 4% - 8% | Below cost of capital, value may be eroding |
| Red flag | < 4% | Significant capital destruction, fundamental issues |
Current: 20.8% (Excellent - Top 50% of sector (median: 9.8%))
Free Cash Flow Margin
The percentage of revenue converted to free cash flow. Higher margins indicate stronger cash generation and business quality.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 20% | Strong cash generation, high-quality business |
| Good | 10% - 20% | Healthy cash conversion |
| Adequate | 5% - 10% | Moderate cash generation |
| Warning | 0% - 5% | Thin cash margins, capital intensive |
| Red flag | < 0% | Cash burn, potential liquidity concerns |
Current: 6.3% (Adequate - Top 50% of sector (median: 3.2%))
Gross Margin
Revenue minus cost of goods sold as a percentage. Higher gross margins indicate pricing power and competitive advantage.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 50% | Strong pricing power and competitive moat |
| Good | 30% - 50% | Healthy margins, differentiated product |
| Adequate | 20% - 30% | Moderate margins, competitive industry |
| Warning | 10% - 20% | Thin margins, commodity-like business |
| Red flag | < 10% | Very thin margins, structural challenges |
Current: 19.7% (Warning - Bottom 25% of sector (median: 40.9%))
P/E Ratio (Price-to-Earnings)
Stock price divided by earnings per share. Lower P/E may indicate undervaluation, while higher P/E suggests growth expectations.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | < 15x | Attractively valued, potential opportunity |
| Good | 15x - 25x | Fair value for quality company |
| Adequate | 25x - 35x | Growth premium, justify with earnings growth |
| Warning | 35x - 50x | High expectations priced in |
| Red flag | > 50x or negative | Speculative valuation or losses |
Current: 38.0x (Adequate)
Free Cash Flow Yield
Free cash flow per share divided by stock price. Higher FCF yield indicates better cash return relative to valuation.
| Rating | Range | Interpretation |
|---|---|---|
| Excellent | > 8% | High cash return, potential value opportunity |
| Good | 5% - 8% | Solid cash yield |
| Adequate | 3% - 5% | Moderate cash return |
| Warning | 1% - 3% | Low cash yield, growth expectations |
| Red flag | < 1% | Minimal cash return to shareholders |
Current: 6.5% (Good)
Frequently Asked Questions
Q: What is Guardian Pharmacy Services, Inc.'s Return on Invested Capital (ROIC)?
Guardian Pharmacy Services, Inc. (GRDN) has a trailing twelve-month Return on Invested Capital (ROIC) of 20.8%. This compares above the sector median of 9.8%. An ROIC above 20% indicates exceptional capital efficiency and strong competitive advantages.
Q: What is Guardian Pharmacy Services, Inc.'s Free Cash Flow Margin?
Guardian Pharmacy Services, Inc. (GRDN) has a free cash flow margin of 6.3%, generating $88.0 million in free cash flow over the trailing twelve months. A FCF margin between 5-10% is typical for capital-intensive businesses.
Q: Is Guardian Pharmacy Services, Inc. stock overvalued or undervalued?
Guardian Pharmacy Services, Inc. (GRDN) trades at a P/E ratio of 38.0x, which is above the sector median of N/A. The EV/Sales multiple is -0.0x. Free cash flow yield is 6.5%, which represents an attractive cash return to investors.
Q: What is Guardian Pharmacy Services, Inc.'s revenue and earnings growth?
Guardian Pharmacy Services, Inc. (GRDN) grew revenue by 18.7% year-over-year. Solid growth above 10% suggests healthy business momentum.
Q: Is Guardian Pharmacy Services, Inc. buying back stock?
Guardian Pharmacy Services, Inc. (GRDN) repurchased $55.2 million of stock over the trailing twelve months. This represents a buyback yield of 4.4%.
Q: How does Guardian Pharmacy Services, Inc. compare to competitors in Consumer Discretionary?
Compared to other companies in Consumer Discretionary, Guardian Pharmacy Services, Inc. (GRDN) shows: ROIC of 20.8% is above the sector median of 9.8% (Top 29%). FCF margin of 6.3% exceeds the sector median of 3.2% (Top 32% of sector). Gross margin at 19.7% is 21.1 percentage points lower than sector peers. These rankings are based on MetricDuck's analysis of all Consumer Discretionary companies with available SEC filings.
Q: What warning signs should I watch for with Guardian Pharmacy Services, Inc.?
Guardian Pharmacy Services, Inc. (GRDN) shows no major financial warning signs based on current metrics. However, investors should always monitor: 1) Margin compression trends, 2) Cash flow consistency, 3) Debt levels relative to cash generation, and 4) Changes in competitive positioning.
Data Source: Data sourced from 10-Q filed 2025-11-10. TTM metrics as of Q3 2025.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
This analysis is for informational purposes only and does not constitute investment advice.